The infection prevention and control community is pondering the Food and Drug Administration (FDA)'s concerns regarding positive-displacement needleless connectors and the possible link to bloodstream infections (BSIs) and patient mortality.
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.